Developing Machine Learning Algorithms for Dynamic Estimation of Progression During Active Surveillance for Prostate Cancer
Overview
Authors
Affiliations
Active Surveillance (AS) for prostate cancer is a management option that continually monitors early disease and considers intervention if progression occurs. A robust method to incorporate "live" updates of progression risk during follow-up has hitherto been lacking. To address this, we developed a deep learning-based individualised longitudinal survival model using Dynamic-DeepHit-Lite (DDHL) that learns data-driven distribution of time-to-event outcomes. Further refining outputs, we used a reinforcement learning approach (Actor-Critic) for temporal predictive clustering (AC-TPC) to discover groups with similar time-to-event outcomes to support clinical utility. We applied these methods to data from 585 men on AS with longitudinal and comprehensive follow-up (median 4.4 years). Time-dependent C-indices and Brier scores were calculated and compared to Cox regression and landmarking methods. Both Cox and DDHL models including only baseline variables showed comparable C-indices but the DDHL model performance improved with additional follow-up data. With 3 years of data collection and 3 years follow-up the DDHL model had a C-index of 0.79 (±0.11) compared to 0.70 (±0.15) for landmarking Cox and 0.67 (±0.09) for baseline Cox only. Model calibration was good across all models tested. The AC-TPC method further discovered 4 distinct outcome-related temporal clusters with distinct progression trajectories. Those in the lowest risk cluster had negligible progression risk while those in the highest cluster had a 50% risk of progression by 5 years. In summary, we report a novel machine learning approach to inform personalised follow-up during active surveillance which improves predictive power with increasing data input over time.
Shen L, Jiang Y, Zhang T, Cao F, Ke L, Li C Cancer Inform. 2024; 23:11769351241289719.
PMID: 39421722 PMC: 11483769. DOI: 10.1177/11769351241289719.
Fang X, Zhong L, Jiang W, Huang C, Lei Y, Tang S iScience. 2024; 27(8):110431.
PMID: 39108708 PMC: 11301085. DOI: 10.1016/j.isci.2024.110431.
Gonzalez R, Saha A, Campbell C, Nejat P, Lokker C, Norgan A J Pathol Inform. 2024; 15:100347.
PMID: 38162950 PMC: 10755052. DOI: 10.1016/j.jpi.2023.100347.
Zhang D, Luan J, Liu B, Yang A, Lv K, Hu P Front Med (Lausanne). 2023; 10:1271687.
PMID: 38098850 PMC: 10720716. DOI: 10.3389/fmed.2023.1271687.
Hsiao Y, Kuo C, Lin F, Wu Y, Lin T, Yeh H Acta Cardiol Sin. 2023; 39(6):901-912.
PMID: 38022427 PMC: 10646597. DOI: 10.6515/ACS.202311_39(6).20230528A.